Education
About Us
Working with TipRanks
Follow Us
Bionovate Technologies (BIIO)
OTHER OTC:BIIO
BIIO Stock Chart & Stats
$0.08
<$0.01(1.00%)
At close: 4:00 PM EST
$0.08
<$0.01(1.00%)
Day’s Range― - ―
52-Week Range$0.01 - $12.45
Previous CloseN/A
Volume1.01K
Average Volume (3M)0.00
Market Cap
$775.00
Enterprise ValueN/A
Total Cash (Recent Filing)$0.00
Total Debt (Recent Filing)$237.53K
Price to Earnings (P/E)―
Beta194.53
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding7,753,598
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)>-0.01
Price to Sales (P/S)0.00
P/FCF Ratio-0.18
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
BIIO FAQ
What was Bionovate Technologies’s price range in the past 12 months?
Bionovate Technologies lowest stock price was $0.01 and its highest was $12.45 in the past 12 months.
What is Bionovate Technologies’s market cap?
Bionovate Technologies’s market cap is $775.00.
When is Bionovate Technologies’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Bionovate Technologies’s earnings last quarter?
Currently, no data Available
Is Bionovate Technologies overvalued?
According to Wall Street analysts Bionovate Technologies’s price is currently Overvalued.
Does Bionovate Technologies pay dividends?
Bionovate Technologies does not currently pay dividends.
What is Bionovate Technologies’s EPS estimate?
Bionovate Technologies’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Bionovate Technologies have?
Bionovate Technologies has 7,753,598 shares outstanding.
What happened to Bionovate Technologies’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Bionovate Technologies?
Currently, no hedge funds are holding shares in BIIO
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Bionovate Technologies
Bionovate Technologies Corp., a medical device company, focuses on developing automated treatment for age spots. It intends to develop automated computerized system that treats age spots anywhere on the body. The company targets to sell its systems to physicians and spas worldwide. The company was formerly known as MJP International Ltd. and changed its name to Bionovate Technologies Corp. in December 2017. Bionovate Technologies Corp. was founded in 2010 and is based in Cham, Switzerland. As of October 7, 2020, Bionovate Technologies Corp. operates as a subsidiary of Human Data AG.
Technical Analysis
Salarius Pharmaceuticals
―
Scinai Immunotherapeutics
―
PainReform
―
NewcelX
―
Akanda Corp
―